Connor, Clark & Lunn Investment Management (CC&L)’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-75,200	Closed	-$391K	–	1091
2016 Q4	$391K	Buy	75,200 +6,900	+10%	+$32.4K	﹤0.01%	658
2016 Q3	$319K	Buy	68,300 +17,900	+36%	+$83.5K	﹤0.01%	663
2016 Q2	$199K	Buy	50,400 +14,300	+40%	+$53.4K	﹤0.01%	744
2016 Q1	$112K	Buy	36,100 +16,000	+80%	+$53.6K	﹤0.01%	762
2015 Q4	$92K	Buy	+20,100	New	+$95.3K	﹤0.01%	764

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s DSCI Position: Q1 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 75,200 shares — an estimated $391K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DSCI in Q4 2015 and held it in 5 quarters. The position peaked at $391K in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 75,200 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $391K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Derma Sciences, Inc. Common Stock (DE) position peaked at $391K in Q4 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2017, filed 15 May 2017.